EUVIMEDEUVIMED entdecken
Open Access

PROTAC-based synthetic lethality strategy endogenously activates systemic STING to boost antitumor immunity

Ye Liu iD, Maolin Jiang, Mengchao Ding, Ihsan Ullah iD, Haiyang Wang, Wenjiao Xie, Kewei Wang iD, Youyong Yuan iD

Science Advances · 27.02.2026 · 12 (9)

DOI: 10.1126/sciadv.ado7448 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 27.02.2026. Verfasst von Ye Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Sciences and Engineering, Guangzhou International Campus, South China University of Technology, Guangzhou 511442, P.R. China. Hauptthemen laut MEDLINE: Membrane Proteins, Synthetic Lethal Mutations, Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Guangdong Provincial Pearl River Talents Program, National Natural Science Foundation of China, China Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Activation of the stimulator of interferon genes (STING) pathway drives natural killer (NK) cells and T cells to orchestrate multidimensional antitumor immune responses. While cytosolic DNA accumulation represents a superior endogenous strategy for STING activation, DNA repair machinery substantially constrains its immunogenic potential. Here, we propose a promising therapeutic strategy that leverages proteolysis-targeting chimera (PROTAC)–mediated degradation of PARP1 [poly(ADP-ribose) polymerase 1] and BRD4 (bromodomain-containing protein 4) to induce synthetic lethality, thereby disrupting DNA repair machinery that drives nuclear-to-cytosolic DNA leakage, surpassing the STING activation threshold to ignite cGAS-STING–mediated innate immunity. Our strategy demonstrates superior antitumor efficacy across multiple tumor models, eliciting robust CD8 + T cell– and NK cell–mediated immunity while suppressing pulmonary metastasis progression. This strategic integration of synthetic lethality with an immunogenic stress response establishes a previously unidentified paradigm for expanding broad applications by cGAS-STING–mediated innate immunity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Membrane ProteinsSynthetic Lethal MutationsNeoplasmsProteolysis Targeting ChimeraSTING ProteinAnimalsImmunity, InnatecGAS-STING Signaling PathwayHumansMiceKiller Cells, NaturalCyclic Guanosine Monophosphate-Adenosine Monophosphate SynthasePoly (ADP-Ribose) Polymerase-1NucleotidyltransferasesDNA RepairCD8-Positive T-LymphocytesCell Line, TumorHost-Directed Therapy

Substanzen

Proteolysis Targeting ChimeraSTING ProteinMembrane ProteinsSting1 protein, mouseCyclic Guanosine Monophosphate-Adenosine Monophosphate SynthasePoly (ADP-Ribose) Polymerase-1NucleotidyltransferasesSTING1 protein, human

Autor:innen und Institutionen

  • School of Biomedical Sciences and Engineering, Guangzhou International Campus, South China University of Technology, Guangzhou 511442, P.R. China.
  • Guangdong Provincial Key Laboratory of Biomedical Engineering, South China University of Technology, Guangzhou 510006, P.R. China.
  • National Engineering Research Center for Tissue Restoration and Reconstruction, South China University of Technology, Guangzhou 510006, P.R. China.
  • Key Laboratory of Biomaterials of Guangdong Higher Education Institutes, Engineering Technology Research Center of Drug Carrier of Guangdong, Department of Biomedical Engineering and MOE Key Laboratory of Tumor Molecula…
  • Key Laboratory of Biomedical Materials of the Ministry of Education, South China University of Technology, Guangzhou 510006, P. R. China.

ORCID-Profile: Ye Liu, Ihsan Ullah, Kewei Wang, Youyong Yuan

Förderung

  • Guangdong Provincial Pearl River Talents Program
  • National Natural Science Foundation of China
  • China Postdoctoral Science Foundation
  • National Key Research and Development Program of China
  • Guangzhou Science and Technology Planning Project

Zitieren

APA

Liu, Y., Jiang, M., Ding, M., Ullah, I., Wang, H., Xie, W., Wang, K., & Yuan, Y. (2026). PROTAC-based synthetic lethality strategy endogenously activates systemic STING to boost antitumor immunity. Science Advances, 12(9). https://doi.org/10.1126/sciadv.ado7448

Vancouver

Liu Y, Jiang M, Ding M, Ullah I, Wang H, Xie W, et al. PROTAC-based synthetic lethality strategy endogenously activates systemic STING to boost antitumor immunity. Science Advances. 2026;12(9). doi:10.1126/sciadv.ado7448

BibTeX
@article{Liu2026,
  author = {Liu, Ye and Jiang, Maolin and Ding, Mengchao and Ullah, Ihsan and Wang, Haiyang and Xie, Wenjiao and Wang, Kewei and Yuan, Youyong},
  title = {PROTAC-based synthetic lethality strategy endogenously activates systemic STING to boost antitumor immunity},
  journal = {Science Advances},
  year = {2026},
  volume = {12},
  number = {9},
  doi = {10.1126/sciadv.ado7448}
}
Kostenlos starten →